Zdrowie i gospodarka · 12/03/2024
FDA Releases Revised Draft Guidance for Early Alzheimer's Disease Treatment
The FDA has made available a revised draft guidance to help pharmaceutical companies develop drugs for treating early stages of sporadic Alzheimer's disease, stages that occur before overt dementia sets in.